Cargando…

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets

Cholesterol is an essential substance in mammalian cells, and cholesterol metabolism plays crucial roles in multiple biological functions. Dysregulated cholesterol metabolism is a metabolic hallmark in several cancers, beyond the Warburg effect. Reprogrammed cholesterol metabolism has been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jiangnan, Siu, Michelle K.Y., Ngan, Hextan Y. S., Chan, Karen K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606538/
https://www.ncbi.nlm.nih.gov/pubmed/34820325
http://dx.doi.org/10.3389/fonc.2021.738177
_version_ 1784602353421254656
author He, Jiangnan
Siu, Michelle K.Y.
Ngan, Hextan Y. S.
Chan, Karen K. L.
author_facet He, Jiangnan
Siu, Michelle K.Y.
Ngan, Hextan Y. S.
Chan, Karen K. L.
author_sort He, Jiangnan
collection PubMed
description Cholesterol is an essential substance in mammalian cells, and cholesterol metabolism plays crucial roles in multiple biological functions. Dysregulated cholesterol metabolism is a metabolic hallmark in several cancers, beyond the Warburg effect. Reprogrammed cholesterol metabolism has been reported to enhance tumorigenesis, metastasis and chemoresistance in multiple cancer types, including ovarian cancer. Ovarian cancer is one of the most aggressive malignancies worldwide. Alterations in metabolic pathways are characteristic features of ovarian cancer; however, the specific role of cholesterol metabolism remains to be established. In this report, we provide an overview of the key proteins involved in cholesterol metabolism in ovarian cancer, including the rate-limiting enzymes in cholesterol biosynthesis, and the proteins involved in cholesterol uptake, storage and trafficking. Also, we review the roles of cholesterol and its derivatives in ovarian cancer and the tumor microenvironment, and discuss promising related therapeutic targets for ovarian cancer.
format Online
Article
Text
id pubmed-8606538
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86065382021-11-23 Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets He, Jiangnan Siu, Michelle K.Y. Ngan, Hextan Y. S. Chan, Karen K. L. Front Oncol Oncology Cholesterol is an essential substance in mammalian cells, and cholesterol metabolism plays crucial roles in multiple biological functions. Dysregulated cholesterol metabolism is a metabolic hallmark in several cancers, beyond the Warburg effect. Reprogrammed cholesterol metabolism has been reported to enhance tumorigenesis, metastasis and chemoresistance in multiple cancer types, including ovarian cancer. Ovarian cancer is one of the most aggressive malignancies worldwide. Alterations in metabolic pathways are characteristic features of ovarian cancer; however, the specific role of cholesterol metabolism remains to be established. In this report, we provide an overview of the key proteins involved in cholesterol metabolism in ovarian cancer, including the rate-limiting enzymes in cholesterol biosynthesis, and the proteins involved in cholesterol uptake, storage and trafficking. Also, we review the roles of cholesterol and its derivatives in ovarian cancer and the tumor microenvironment, and discuss promising related therapeutic targets for ovarian cancer. Frontiers Media S.A. 2021-11-08 /pmc/articles/PMC8606538/ /pubmed/34820325 http://dx.doi.org/10.3389/fonc.2021.738177 Text en Copyright © 2021 He, Siu, Ngan and Chan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
He, Jiangnan
Siu, Michelle K.Y.
Ngan, Hextan Y. S.
Chan, Karen K. L.
Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
title Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
title_full Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
title_fullStr Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
title_full_unstemmed Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
title_short Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
title_sort aberrant cholesterol metabolism in ovarian cancer: identification of novel therapeutic targets
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606538/
https://www.ncbi.nlm.nih.gov/pubmed/34820325
http://dx.doi.org/10.3389/fonc.2021.738177
work_keys_str_mv AT hejiangnan aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets
AT siumichelleky aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets
AT nganhextanys aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets
AT chankarenkl aberrantcholesterolmetabolisminovariancanceridentificationofnoveltherapeutictargets